Nordihydroguaiaretic Acid Blocks IL-2-Independent Lymphocyte Proliferation and Enhances Responses to PPD

A. H. Esa, P. J. Converse

Research output: Contribution to journalArticlepeer-review


The authors examined the mechanism by which the non-specific lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA) inhibits human lymphocyte proliferative responses and compared its effects with those of cyclosporine (CsA). It was found that CsA-resistant proliferative responses induced by direct PK-C activators such as mitogenic concentrations of the phorbol ester TPA or the putative antitumour agent bryostatin 1 (bryo 1) were inhibited in a concentration-dependent manner by NDGA (IC50 = 2 μM). In contrast, CsA-sensitive IL-2-dependent proliferative responses induced by PHA, anti-CD3 or the purified protein derivative (PPD) of M. tuberculosis were not significantly inhibited by NDGA concentrations as high as 8 μM. The expression of the IL-2R by lymphocytes was also resistant to NDGA concentrations that effectively blocked the mitogenic effects of TPA or bryostatin, but could be inhibited by higher concentrations of NDGA (IC50 = 8 μM). In addition, NDGA, but not CsA, blocked the production of IL-6 by human mononuclear cells. Furthermore, PPD-induced proliferation was significantly enhanced by NDGA. These data would suggest that NDGA at concentrations below 8 μM selectively inhibits IL-2-independent proliferation. NDGA's ability to inhibit IL-6 while enhancing the proliferative response to PPD may indicate an anti-inflammatory therapeutic potential of anti-oxidants in mycobacterial infections.

Original languageEnglish (US)
Pages (from-to)127-133
Number of pages7
JournalScandinavian Journal of Immunology
Issue number2
StatePublished - 1996

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Nordihydroguaiaretic Acid Blocks IL-2-Independent Lymphocyte Proliferation and Enhances Responses to PPD'. Together they form a unique fingerprint.

Cite this